Serial Number | 98440296 |
Word Mark | ZENTRUDO |
Filing Date | Friday, March 8, 2024 |
Status | 730 - FIRST EXTENSION - GRANTED |
Status Date | Wednesday, May 28, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, November 5, 2024 |
Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the skin, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of oncological and metabolic diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, March 8, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Teva Pharmaceuticals International GmbH |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 16 - Limited Liability Company |
Address | Jona 8645 CH |
Party Name | Teva Pharmaceuticals International GmbH |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Jona 8645 CH |
Event Date | Event Description |
Friday, March 8, 2024 | NEW APPLICATION ENTERED |
Friday, March 8, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 24, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 24, 2024 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, September 25, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, September 19, 2024 | ASSIGNED TO EXAMINER |
Tuesday, September 24, 2024 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, September 24, 2024 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, October 16, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, November 5, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, December 17, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, November 5, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, May 28, 2025 | SOU TEAS EXTENSION RECEIVED |
Wednesday, May 28, 2025 | SOU EXTENSION 1 FILED |
Wednesday, May 28, 2025 | SOU EXTENSION 1 GRANTED |